Antiproliferative effects of daucane esters from Ferula communis and F. arrigonii on human colon cancer cell lines

Phytotherapy Research

Volumn 19, Issue 2, 2005, Pages 152-157

  Poli, F ^a   Appendino, G ^b   Sacchetti, G ^c   Ballero, M ^d   Maggiano, N ^e   Ranelletti, F O ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiproliferative effects; Binding to Type II EBS; Daucane esters; F. arrigonii; Ferula communis

Indexed keywords

4 HYDROXYBENZOIC ACID; ANISIC ACID; DAUCANE ESTER; ESTER; FERULA ARRIGONII EXTRACT; FERULA COMMUNIS EXTRACT; FERUTIDIN; FERUTIDIN SIOL ANISATE; FERUTININ; JAESEKANADIOL; LAPIFERIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLONOGENIC ASSAY; COLON CANCER; CONTROLLED STUDY; ESTROGEN BINDING; FERULA ARRIGONII; FERULA COMMUNIS; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; ITALY; MEDICINAL PLANT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FERULA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS;

FERULA ARRIGONII; FERULA COMMUNIS;

EID: 18444375842     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1443     Document Type: Article

References (19)

1. Appendino G. 1997. The Toxins of Ferula communis. In Virtual Activity, Real Pharmacology, Verotta L (ed.). Research Signpost: Trivandrum; 1-15.
2. Appendino G, Jakupovic J, Alloatti S, Ballero M. 1997. Daucane Esters from Ferula arrigonii. Phytochemistry 45: 1639-1643.
3. Appendino G, Cravotto G, Sterner O, Ballero M. 2000. Oxygenated Sesqiterpenoids from a non-poisonous Sardinia Chemotype of giant Fennel (Ferula communis). J Nat Prod 64: 393-395.
4. Arai N, Strom A, Rafter JJ, Gustafsson JA. 2000. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biopyhys Res Commun 270: 425-431.
5. Ferrandina G, Almadori G, Maggiano N, et al. 1998. Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors. Int J Cancer 77: 747-54.
6. Ferrandina G, Scambia G, Benedetti Panici P, et al. 1993. Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor. Gynecol Oncol 49: 67-72.
7. Ghisalberti EL. 1994. The Daucane (Carotane) Class of Sesquiterpenes. Photochemistry 37: 597-611.
8. Gonzales AG, Bermejo Barrera JB. 1995. Chemistry and Sources of Mono- and Bicyclic Sesquiterpenes from Ferula Species. In Progress in the Chemistry of Organic Natural Products, Herz W, Kirby GW, Moore RE, et al. (eds). Springer: Wien; 1-92.
9. Hamburger AW, Salmon SE. 1977. Primary bioassay of human stem cell. Science 197: 461-463.
10. Ikeda K, Arao Y, Otsuka H, et al. 2002. Terpenoids found in the Umbelliferae family act as agonist/antagonists for ERα and ERβ: differential transcription activity between ferutinine-liganded ERα and ERβ. Biochem Biopyhys Res Commun 291: 354-360.
11. Markaverich BM, Gregory RR, Alejandro MA, et al. 1988. Methyl p-Hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear Type II EBS. J Biol Chem 263: 7203-7210.
12. Ondeyka GG, Ball RG, Garcia ML, et al. 1995. A carotane sesquiterpene as a potent modulator of the maxi-k channel from Arthrinium Phaesospermum. Bioorg Med Chem Lett 5: 733-734.
13. Piantelli M, Maggiano N, Ricci R, et al. 1995. Type II estrogen binding sites in human melanoma and growth inhibitory effect of tamoxifen and quercetin. J Invest Dermatol 105: 248-253.
14. Ranelletti FO, Scambia G, Benedetti-Panici P, et al. 1995. Expression of methyl-p-parahydroxyphenyllactate esterase activity and Type II estrogen binding sites (Type II EBS) in ovarian cancer: correlation with biological and clinicopathological parameters. Int J Cancer 62: 536-541.
15. Ranelletti FO, Ricci R, Larocca LM, et al. 1992. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50: 486-492.
16. Sacchetti G, Appendino G, Ballero M. 2003. Vittae fluorescence as a tool to differentiate between poison and non-poison populations of giant fennel (Ferula communis L.) of Sardinia island (Italy). Biochem Syst Ecol 31: 527-534.
17. Scambia G, Ranelletti FO, Benedetti-Panici P, et al. 1991. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chem Pharm 28: 255-258.
18. Scambia G, Ranelletti FO, Benedetti-Panici P, et al. 1992. Synergistic Antiproliferative Activity of Tamoxifen and Cisplatin on Primary Ovarian Tumours. Eur J Cancer 28: 1885-1889.
19. Syne JS, Markaverich BM, Clark JH, Panko WB. 1982. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple binding sites. Cancer Res 42: 4449-4456.